Geisinger launches opioid reduction initiative

Danville, Pa.-based Geisinger has launched a surgical redesign program to improve pain management and reduce patient opioid use.

Here are three things to know:

1. Geisinger's program is called ProvenRecovery, and it will be implemented for 42 surgical procedures. This will affect about 15,000 surgery cases annually. Geisinger's goal is to reach 100 surgical specialties by the end of next year.

2. Geisinger's ProvenRecovery pilot started in June 2017 and drove down the health center's patient opioid use by 18 percent. During the pilot, Geisinger's neurosurgery and colorectal surgery patients had earlier discharges which saved an average $4,556 per colorectal surgery patient.

3. ProvenRecovery focuses on giving patients proper nutrition before surgery to boost their immune systems, appropriate pain management using nonopioids, and postsurgery mobility routines.

"Since the early '90s, Geisinger has been pioneering patient-centric programs that revolutionize care design and management, paving the way for the industry in the move to value," Jaewon Ryu, MD, Geisinger’s interim president and chief executive officer, said. "ProvenRecovery is a natural evolution of these efforts, building on the successes of our ProvenCare program. By getting patients healthier and out of the hospital sooner, not only are we improving lives, we’re also reducing overall costs of care."

More articles on opioids:

Massachusetts lost $15.2B to opioid epidemic in 2017
Opioid overdose 'silver lining': Organ donations up in Philadelphia
Pharmacies fall short on stocking naloxone despite anti-overdose initiatives

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers